Cascade of fever production in mice infected with influenza virus

Journal of Medical Virology

Volumn 50, Issue 2, 1996, Pages 152-158

  Kurokawa, Masahiko ^a   Imakita, Masami ^b   Kumeda, Cristina A ^a   Shiraki, Kimiyasu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cyclooxygenase activity; Cytokines; Fever; Influenza virus; Interferon; Interleukin 1

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; INTERLEUKIN 1ALPHA; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FEVER; INFLUENZA; INFLUENZA VIRUS; MOUSE; NONHUMAN;

ANIMALS; ANTIBODIES; CELL LINE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FEVER; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERON-ALPHA; INTERLEUKIN-1; MICE; MICE, INBRED STRAINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

ANIMALIA; INFLUENZA VIRUS; MURINAE;

EID: 0029916060     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199610)50:2<152::AID-JMV8>3.0.CO;2-9     Document Type: Article

References (26)

1. 2 production and sphingomyelin metabolism: Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. Journal of Biological Chemistry 267:20044-20050.
2. Bernheim HA, Block LH, Francis L, Atkins E (1980): Release of endogenous pyrogen-activation factor from concanavalin A-stimulated human lymphocytes. Journal of Experimental Medicine 152:1811-1816.
3. Blatteis CM (1982): Role of the OVLT in the febrile response to circulating pyrogens. Progress in Brain Research 91:409-412.
4. Bodel P, Reynolds CF, Atkins E (1973): Lack of effect of salicylate on pyrogen release from human blood leukocytes in vitro. Yale Journal of Biology and Medicine 46:190-195.
5. Clark WG, Moyer SG (1972): The effects of acetaminophen and sodium salicylate on the release and activity on leukocytic pyrogen in the cat. Journal of Pharmacology and Experimental Therapeutics 181:183-191.
6. Dinarello CA (1981): Demonstration of a human pyrogen-inducing factor during mixed leukocyte reactions. Journal of Experimental Medicine 153:1215-1224.
7. Dinarello CA, Cannon JG, Wolff SM (1988): New concepts on the pathogenesis of fever. Reviews of Infectious Diseases 10:168-189.
8. Duff GW, Durum SK (1983): The pyretic and mitogenic actions of interleukin-1 are related. Nature 304:449-451.
9. Flower RJ, Vane JR (1972): Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 240:410-411.
10. Ginsberg HS, Horsfall FL Jr (1952): Quantitative aspects of the multiplication of influenza A virus in the mouse lung. Journal of Experimental Medicine 95:135-145.
11. Hashimoto M, Ishikawa Y, Yokota S, Goto F, Bando T, Sakakibara Y, Iriki M (1991): Action site of circulating interleukin-1 on the rabbit brain. Brain Research 540:217-223.
12. Hennet T, Ziltener HJ, Frei K, Peterhans E (1992): A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. Journal of Immunology 149:932-939.
13. Hert JF, Mulder J, Masurel N, Kuip LVD (1962): Studies on the pathogenesis of influenza virus peumonia in mice. Journal of Pathology and Bacteriology 83:207-217.
14. Hurd J, Heath RB (1975): Effect of cyclophosphamide on infections in mice caused by virulent and avirulent strains of influenza virus. Infection and Immunity 11:886-889.
15. Insel PA (1990): Analgesic-antipyretics and antiinflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout. In: "Goodman and Gilman's The Pharmacological Basis of Therapeutics." Ed. Goodman Gilman A, Rall TW, Nies AS, and Taylor P. New York: Pergamon Press, pp. 638-681.
16. Kurokawa M, Hase K, Xu H-X, Yamamura Y, Koyasu M, Sato H, Kadota S, Hozumi T, Namba T, Shiraki K (1993a): A novel procedure for the identification of a fraction with anti-herpes simplex virus type 1 activity in vivo from hot-water extract of traditional medicines, Geum japonicum THUNB. Journal of Medical and Pharmaceutical Society for WAKAN-YAKU 10:195-203.
17. Kurokawa M, Nagasaka K, Hirabayashi T, Uyama S, Sato H, Kageyama T, Kadota S, Ohyama H, Hozumi T, Namba T, Shiraki K (1995): Efficacy of traditional herb medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Research 27:19-37.
18. Kurokawa M, Ochiai H, Kazuhiko N, Neki M, Xu H, Kadota S, Sutardjo S, Matsumoto T, Namba T, Shiraki K (1993b): Antiviral traditional medicines against herpes simplex virus (HSV-1), poliovirus and measles virus in vitro and their therapeutic efficacies for HSV-1 infection in mice. Antiviral Research 22:175-188.
19. Murphy BR, Chalhub EG, Nusinoff SR, Kasel J, Chanock RM (1973): Temperature-sensitive mutants of influenza virus. III. Further characterization of the ts-1[E] influenza A recombinant (H3N2) virus in man. Journal of Infectious Diseases 128:479-487.
20. Nagasaka K, Kurokawa M, Imakita M, Shiraki K (1995): Efficacy of Kakkon-to, a traditional herb medicine, in herpes simplex virus type 1 infection in mice. Journal of Medical Virology 46:28-34.
21. Saper CB, Breder CD (1992): Endogenous pyrogens in the CNS: role in the febrile response. Progress in Brain Research 93:419-429.
22. Strijbos PJLM, Horan MA, Carey F, Rothwell NJ (1993): Impaired febrile responses of aging mice are mediated by endogenous lipocortin-1 (annexin-1). American Journal of Physiology 265:E289-297.
23. Sullivan JL, Mayner RE, Barry DW, Ennis FA (1976): Influenza virus infection in nude mice. Journal of Infectious Diesases 133:91-94.
24. Tashiro M, Ciborowski P, Klenk H-D, Pulverer G, Rott R (1987a): Role of Staphylococcus aureus in the development of influenza pneumonia. Nature, London 325:536-537.
25. Tashiro M, Ciborowski P, Reinacher M, Pulverer G, Klenk H-D, Rott R (1987b): Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology 157:421-430.
26. Taylor PM, Meager A, Askonas BA (1989): Influenza virus-specific T cells lead to early interferon γ in lungs of infected hosts: Development of a sensitive radioimmunoassay. Journal of General Virology 70:975-978.